Publication | Closed Access

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Hematological MalignancyImmunohematologyComplement 1Ofatumumab Versus ChlorambucilLymphoid NeoplasiaOpen-label Phase 3MedicineImmunologyHematologyImmune Checkpoint InhibitorAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyHealth Sciences